Prevention of deep vein thrombosis with low molecular-weight heparin in patients undergoing total hip replacement
- 1 February 1992
- journal article
- clinical trial
- Published by Springer Nature in Archives of orthopaedic and trauma surgery
- Vol. 111 (2), 110-120
- https://doi.org/10.1007/bf00443477
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Prevention of deep vein thrombosis after hip replacement: randomised comparison between unfractionated heparin and low molecular weight heparin.BMJ, 1991
- Comparison of a low molecular weight heparin and unfractionated heparin for the prevention of deep vein thrombosis in patients undergoing abdominal surgeryBritish Journal of Surgery, 1988
- Heparin/dihydroergotamine for venous thrombosis prophylaxis: comparison of low-dose heparin and low molecular weight heparin in hip surgeryBritish Journal of Surgery, 1988
- Reduction in Fatal Pulmonary Embolism and Venous Thrombosis by Perioperative Administration of Subcutaneous HeparinNew England Journal of Medicine, 1988
- Spinal Subarachnoid Hematoma after Lumbar Puncture and HeparinizationAnesthesia & Analgesia, 1986
- A Randomized Controlled Trial of a Low-Molecular-Weight Heparin (Enoxaparin) to Prevent Deep-Vein Thrombosis in Patients Undergoing Elective Hip SurgeryNew England Journal of Medicine, 1986
- Efficacy and safety of low-molecular-weight heparin (CY216) in preventing postoperative venous thrombo-embolism: A co-operative studyBritish Journal of Surgery, 1985
- Adjusted versus Fixed-Dose Subcutaneous Heparin in the Prevention of Deep-Vein Thrombosis after Total Hip ReplacementNew England Journal of Medicine, 1983
- Failure of Low Dose Heparin to Prevent Pulmonary Embolism After Hip Surgery Or Above The Knee AmputationAnnals of Surgery, 1978
- EFFICACY OF LOW-DOSE HEPARIN IN PREVENTION OF EXTENSIVE DEEP-VEIN THROMBOSIS IN PATIENTS UNDERGOING TOTAL-HIP REPLACEMENTThe Lancet, 1976